GRCE READ THE FULL GRCE RESEARCH REPORT Grace Therapeutics, Inc (NASDAQ:GRCE) will soon submit its new drug application (NDA) ...

Gland Pharma receives USFDA approval for Angiotensin II Acetate Injection, a generic drug with exclusive rights and high ...

Tenpoint Therapeutics, Ltd. ("Tenpoint"), a global, clinical-stage biotechnology company focused on developing groundbreaking treatments to rejuvenate vision in the aging eye, today announces that the ...

The U.S. Food and Drug Administration (FDA) accepted the New Drug Application (NDA) for ziftomenib, an investigational ...

SHELTON, CT / ACCESS Newswire / June 4, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the “Company ...

The Food and Drug Administration (FDA) has accepted for Priority Review the New Drug Application (NDA) for ziftomenib as a treatment for adult patients with relapsed or refractory (R/R) acute myeloid ...

Tenpoint Therapeutics announced that the new drug application (NDA) for its presbyopia candidate, brimochol PF, has been ...

has accepted the New Drug Application (NDA) resubmission for investigational ND0612, a 24-hours/day, continuous, subcutaneous (SC) infusion of liquid levodopa/carbidopa (LD/CD), for the treatment ...

The development of innovative pharmaceuticals targeting refractory mental health conditions has stagnated for decades. In recent years, ...

US FDA accepts Tenpoint Therapeutics’ NDA for Brimochol PF for the treatment of presbyopia: London, UK Wednesday, June 4, 2025, 15:00 Hrs [IST] Tenpoint Therapeutics, Ltd. (Tenp ...

Hyderabad: Gland Pharma Limited, a generic injectable & ophthalmicfocused pharmaceutical company, has announced that the ...

XP 8121 is a combination drug meant to better control hypothyroidism, in part by moving its common therapy, levothyroxine, ...